Glioblastoma is the most aggressive brain tumor with a median survival of less than 15 months.
The complex interactions between the tumor and the cells of the tumor microenvironment …

OBJECTIVE Giant pituitary adenomas (PAs), defined as 4 cm or greater at their maximum
diameter, are commonly treated with neurosurgical intervention as the first-line therapy. …

Cancer-associated fibroblasts (CAFs) were presumed absent in glioblastoma given the lack
of brain fibroblasts. Serial trypsinization of glioblastoma specimens yielded cells with CAF …

Background Head and neck osteosarcoma (HNOS) is a rare primary bone tumor with limited
data to guide treatment approaches. Methods The NCDB was used to identify patients …

OBJECTIVE Decision-making in how to manage pituitary adenomas (PAs) in the elderly (age
≥ 65 years) can be challenging given the benign nature of these tumors and concerns …

OBJECTIVE Maximal safe resection is the standard of care for patients presenting with
lesions concerning for glioblastoma (GBM) on magnetic resonance imaging (MRI). Currently, …

Purpose The role of an osseous-only posterior fossa decompression (PFD) for Chiari
malformation type 1 (CM1) remains controversial. We reviewed long-term outcomes for patients …

Background: Anterior lumbar interbody fusion (ALIF) has become an increasingly popular
and effective treatment modality for various conditions of the lumbar spine. However, …

BACKGROUND CONTENT Diffuse gliomas of the spine (DGS)—consisting of intradural
intramedullary glioblastoma, astrocytoma, and oligodendroglioma—are exceedingly rare tumors …

Objective To examine complication rates and radiographic outcomes in patients undergoing
surgery for adult spinal deformity (ASD) by a junior surgeon. Methods A study was …